company-logo

Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100, which is in Phase I trials for the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 that is in preclinical trials to treat and manage various eye diseases, including uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. was founded in 2012 and is headquartered in San Diego, California.

Skye Bioscience Dividend Announcement

Skye Bioscience does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on Skye Bioscience dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Skye Bioscience Dividend History

Skye Bioscience Dividend Yield

Skye Bioscience current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Skye Bioscience stock? Use our calculator to estimate your expected dividend yield:

Skye Bioscience Financial Ratios

P/E ratio-7.49
PEG ratio-44.38
P/B ratio2.10
ROE-37.70%
Payout ratio0.00%
Current ratio14.19
Quick ratio14.19
Cash Ratio11.99

Skye Bioscience Dividend FAQ

Does Skye Bioscience stock pay dividends?
Skye Bioscience does not currently pay dividends to its shareholders.
Has Skye Bioscience ever paid a dividend?
No, Skye Bioscience has no a history of paying dividends to its shareholders. Skye Bioscience is not known for its dividend payments.
Why doesn't Skye Bioscience pay dividends?
There are several potential reasons why Skye Bioscience would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Skye Bioscience ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Skye Bioscience has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Skye Bioscience a dividend aristocrat?
Skye Bioscience is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Skye Bioscience a dividend king?
Skye Bioscience is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Skye Bioscience a dividend stock?
No, Skye Bioscience is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Skye Bioscience stocks?
To buy Skye Bioscience you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Skye Bioscience stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.